Idinvest Partners and Kurma Life Sciences Partners Celebrate Prosensa IPO

Dutch biotechnology company Prosensa Holding has started its first trading day on the Nasdaq New York, US. Prosensa is the second Idinvest portfolio company completing a market listing this year. Earlier in 2013, Erytech Pharma, a French company specialized in innovative therapeutic approach for cancers was admitted on NYSE Euronext Paris.

Gentical Raises $23.7M From Wellington, EdRIP, InnoBio, Others

Wellington Partners said it is the lead investor in a $23.7 million Series C financing round for Genticel which was closed this week. Wellington Partners committed about $5 million and the remaining came from existing shareholders, including EdRIP, IDInvest, InnoBio, IRDI and Amundi. The funds will be used primarily to finance a phase II program for the Toulouse, France-based HPV- vaccine developer’s lead product ProCervix.

Wellington Leads Genticel Financing

Wellington Partners has led a 18.2 million euros series C financing round at Toulouse/France-based therapeutic HPV- vaccine developer Genticel. Wellington Partners committed 4 million euros to this financing. The remaining 14.2 million euros were provided by the existing shareholders including EdRIP, IDInvest, InnoBio, IRDI and Amundi.

PEHUB Community

Join the 12502 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

Psst! Got any hot tips?

  • This field is for validation purposes and should be left unchanged.

PE HUB News Briefs

RSS Feed Widget

Marketplace

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget

Reuters VC and PE feed

RSS Feed Widget